Canaccord Genuity Downgrades Bioceres Crop Solutions to Hold, Lowers Price Target to $2.5
Author: Benzinga Newsdesk | September 10, 2025 06:17am
Canaccord Genuity analyst Austin Moeller downgrades Bioceres Crop Solutions (NASDAQ:BIOX) from Buy to Hold and lowers the price target from $6.5 to $2.5.